Actively Recruiting
STUDY INCIDENCE AND CHARACTERISTICS OF MALIGNANT NEOPLASIES IN PATIENTS WITH HEMOGLOBINOPATHY FOLLOWED IN ITALY
Led by Società Italiana Talassemie ed Emoglobinopatie · Updated on 2022-04-01
10000
Participants Needed
1
Research Sites
1569 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Trial aims to increase the information available on the relevance of tumor pathology in hemoglobinopathies, updating the data relating to hepatocarcinoma and investigating which other tumors are more frequent in patients with hemoglobinopathies. Still, in relation to tumor pathology, the study will evaluate any differences between the different types of hemoglobinopathy and will investigate the association between the appearance of neoplasms and risk factors such as age, sex, iron accumulation markers, history of bone marrow transplant, and others.
CONDITIONS
Official Title
STUDY INCIDENCE AND CHARACTERISTICS OF MALIGNANT NEOPLASIES IN PATIENTS WITH HEMOGLOBINOPATHY FOLLOWED IN ITALY
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of transfusion-dependent or transfusion-independent beta-thalassemia, hemoglobin H disease, sickle cell anemia, or microdrepanocytosis
- Current or previous diagnosis of malignant tumor
- Availability of medical history including relevant clinical and instrumental data before cancer onset
You will not qualify if you...
- Presence of other hematological diseases besides hemoglobinopathies
- No history of neoplastic (tumor) events
- Lack of relevant clinical and instrumental data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Azienda Ospedaliera Universitaria Di Cagliari
Cagliari, Italy, 09121
Actively Recruiting
Research Team
R
RAFFAELLA ORIGA, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here